Hospira Inc. Company Profile

Description: Hospira Inc.

Hospira, Inc., a specialty pharmaceutical and medication delivery company, develops, manufactures, and markets pharmaceuticals and medication delivery systems in the United States and internationally. It offers generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems for hospitals, wholesalers, integrated delivery networks, and alternate site providers, such as clinics, home healthcare providers, and long-term care facilities. The company primarily provides specialty injectable pharmaceutical products that consist of generic injectable pharmaceuticals for analgesia, anesthesia, anti-infective, cardiovascular, and oncology therapeutic areas, as well as Precedex (dexmedetomidine HCl), a proprietary sedative. Its proprietary drug delivery options include Carpuject and iSecure prefilled syringes, Ansyr prefilled needleless emergency syringe systems, First Choice ready-to-use premixed formulations, and the ADD-Vantage System for preparing drug solutions from prepackaged drug powders or concentrates. The company also offers infusion therapy solutions and supplies that include I.V. solutions for general use; and I.V. nutrition products and solutions for the washing and cleansing of wounds or surgical sites. In addition, it provides medication management systems that include electronic drug delivery pumps, safety software, and administration sets that are used to deliver I.V. fluids and medications. Further, the company offers gravity administration sets, formulation development, and injectable and oral drug filling and finishing services. Hospira, Inc. was founded in 2003 and is headquartered in Lake Forest, Illinois.

Company Profile

$24.95

 

 Hospira, Inc. (Hospira) is a specialty pharmaceutical and medication delivery company. Hospira's portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems. Hospira's pr...

Close Viewer

$125.00

 

 Hospira, Inc. (HSP) - Financial and Strategic SWOT Analysis Review Summary Hospira, Inc. (Hospira) is a global specialty pharmaceutical and medication delivery company. The company develops, manufactures and markets products that help improv...

Close Viewer

Prospectus IPO Registration and Annual Reports

 

 This is the 2009 annual report for Hospira, Inc a publicly traded company. The report contains assessments of the year’s operations, business and financial highlights, company’s view of the upcoming year and their prospects in their industries.

Close Viewer

Prospectus IPO Registration and Annual Reports

 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer

Company Agreements and Contracts

 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer

Cart Summary

Cart items will instantly download upon purchase.

There are no items in your cart
Your Savings: $0.00
Your Total: $0.00

Contact Info

Address:
275 North Field Drive, Lake Forest,IL 60045, United States
Phone:
224-212-2000
Revenue:
3.98B
Employees:
13500
Website:
http://www.hospira.com

Executive Team

Mr. Christopher B. Begley
57, Chairman, Chief Exec. Officer and Member of Science & Technology Committee
Mr. Thomas E. Werner
52, Chief Financial Officer and Sr. VP of Fin.
Mr. Terrence C. Kearney
55, Chief Operating Officer
Mr. Ron Squarer Bsc (biochemistry)mba
43, Chief Commercial Officer and Sr. VP
Dr. Sumant Ramachandra M.D., Ph.D
41, Chief Scientific Officer and Sr. VP of R&D & Medical Affairs

Competitors

BAX
Baxter International Inc.